Skip to main content
TipRanks
Go Ultimate75% OFF

FIGS (FIGS) Q3 2026 Earnings Report

479 Followers

FIGS Q3 2026 EPS Results

Actual EPS
$0.10
Consensus EPS
$0.07
Beat/Miss
Beat by +$0.03
One Year Ago EPS
$0.05

FIGS Q3 2026 Revenue Results

Actual Revenue
$190.69M
Expected Revenue
$182.82M
Beat/Miss
Beat by +$7.87M
YoY Revenue Growth
+25.73%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/05/2026
Time
After Close
Conference Call
Thursday, November 5, 2026
FIGS Upcoming Earnings

FIGS's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

FIGS Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 05, 2026|% Change Since:2.82%|
Earnings Call Sentiment|Positive

The call was strongly positive. FIGS reported four consecutive quarters of greater than 25% growth, broad-based revenue and customer momentum, substantial profitability improvement, a record cash position, and raised full-year revenue and margin guidance. The main challenges were supplier-transition disruptions, stockouts, ongoing freight and duty costs, the difficult Q4 comparison, and a projected 2027 headwind from the expiration of tariff-refund benefits. Management nevertheless expressed confidence in improving inventory availability and continued growth across the U.S., international markets, TEAMS, Community Hubs, and new product categories.

Company Guidance

FIGS expects Q4 net revenue growth of approximately 15% year-over-year, or growth in the mid-teens range, on top of 33% growth in Q4 last year, resulting in an implied two-year stack of nearly 50%; full-year 2026 net revenue growth is expected to be approximately 23.5% year-over-year, with GAAP gross margin of approximately 69.9%, operating margin of approximately 12%, and adjusted EBITDA margin of approximately 15.8%, up from the prior range of between 14.8% and 15%. Inventory is expected to remain down year-over-year for Q4 before beginning to rebuild in 2027, while the Jordan situation will impact Q4 the most and have some impact all the way through Q2 of next year; FIGS expects its discipline around profitability to continue in 2027, and described a normalized gross margin of 67.5-ish this year and said it expects to be in that range for next year.

  • Broad-Based Q3 Revenue OutperformanceNet revenues increased 26% year-over-year to $190.7 million, ahead of the approximately 20% outlook and marking FIGS' fourth consecutive quarter of greater than 25% growth. Strength was broad-based across categories, channels, and geographies.
  • Customer Metrics Continued to AccelerateActive customers increased 14% year-over-year to nearly 3.2 million, average order value increased 11% to $126, and net revenues per active customer increased 13% to a record $236. The company also reported improving order frequency among returning customers.
  • Improved Profitability and Operating LeverageAdjusted EBITDA margin expanded 410 basis points year-over-year to 16.5%, exceeding the approximately 14% outlook. Operating margin increased 520 basis points to 11.6% from 6.4%, while lower selling, marketing, and G&A expense rates reflected revenue leverage and efficiency initiatives.
  • Strong Gross Margin Despite HeadwindsQ3 gross margin was 69.3%, ahead of expectations and described as remaining strong. Positive impacts from pricing, costing, higher full-price selling, lower return rates, and product mix helped offset higher inventory reserves and the comparison against a favorable prior-year returns-processing benefit.
  • Category Growth Across Scrubwear and Non-ScrubwearScrubwear revenue grew 24% and represented 83% of net revenues, supported by core styles, limited-edition colors, and expanded FIBREx styles. Non-scrubwear revenue grew 35% and represented 17% of net revenues, with contributions from underscrubs, outerwear, footwear, and accessories.
  • International Revenue Growth SurgedInternational net revenues increased 51% year-over-year to $36.8 million and approached 20% of total business. Growth was particularly strong in Latin America, Mexico, the Middle East, and Europe, while nearly 90% of Q3 international growth came from existing comparable markets.
  • U.S. Business Maintained Strong MomentumU.S. net revenues increased 21% year-over-year to $153.9 million, marking four consecutive quarters of more than 20% growth in the United States. The company reported continued gains in site traffic, search trends, social followers, and email and SMS subscribers.
  • Raised Full-Year and Q4 Revenue OutlookQ4 revenue is now expected to grow approximately 15% year-over-year. Full-year 2026 net revenue growth is expected to be approximately 23.5%, up from the prior outlook of approximately 20% and roughly double the high end of the original outlook provided in February.
  • Raised Full-Year Margin OutlookFull-year GAAP gross margin is now expected to be approximately 69.9%, compared with the prior outlook of approximately 69.5%. Operating margin guidance increased to approximately 12% from approximately 10.8%, and adjusted EBITDA margin guidance increased to approximately 15.8% from the prior range of 14.8% to 15%.
  • Record Cash Position and Share RepurchasesCash equivalents and short-term investments reached a record $331.2 million, up 37% year-over-year and approximately 10% above the prior peak in Q4 2025. FIGS repurchased approximately $14 million of shares during Q3 at a weighted average price of $14.02 per share, had deployed approximately $60 million year-to-date for repurchases and net share settlement, and had approximately $105 million remaining under its authorization at quarter-end.
  • Inventory Optimization and Supply Chain DiversificationInventory decreased 20% year-over-year to $121.3 million, reflecting supplier transitions, strong sales, and optimization efforts. FIGS secured additional capacity in Vietnam, expedited goods, and plans to begin initial production lines in Indonesia in Q4, with Indonesia expected to support a more meaningful mix of business by the end of 2027.
  • Product Innovation and Strong LaunchesQ3 launches including Spider-Man, back-to-school, espresso, and breast cancer awareness collections generated broad-based excitement. The new durable FIBREx fabrication exceeded expectations, while new waistband solutions, fabrics, colors, and styles expanded the scrubwear offering.
  • CHARxMACY Launch Demonstrated DemandFollowing the V Coterie acquisition, FIGS launched CHARxMACY in August with jewelry, pins, charms, and accessories designed for healthcare professionals. Much of the original launch sold out, and the company accumulated a waiting list of nearly 10,000 healthcare professionals ahead of rebuilding the assortment for the holidays.
  • Community Hub Performance and ExpansionCommunity Hubs delivered another quarter of double-digit comparable-store growth, while non-comparable performance exceeded expectations. Four additional 2026 locations are planned for Tyson's Corner, Fashion Square in Scottsdale, Aventura Mall, and Valley Fair near San Jose. Management cited a higher mix of new customers, payback well under the two-year target, and accretive margins.
  • TEAMS Business Continued to ScaleTEAMS growth is inflecting higher and outpacing total revenue growth. The new Team Store, launched in March, added self-serve, concierge, and stipend functionality, while partnerships with Bupa Dental Care and European Wax Center provided examples of larger institutional opportunities. The company also reported reducing some sales cycles to a number of months from potentially a year or more.
  • Non-Scrubwear Attachment Rate IncreasedThe non-scrubwear attachment rate was described as being in the mid-20s and increasing year-over-year. FIGS cited continued opportunities from outerwear, underscrubs, footwear, compression socks, jewelry, accessories, and the planned ThermaC offering.
  • Brand and Marketing Execution StrengthenedFIGS extended its brand campaigns through "Never Change," leveraged viral moments involving the Olympics and Noah Lyles, expanded advocacy, and increased sophistication across the full marketing funnel. Marketing expense declined to 13.4% of net revenues from 15.5% last year, reflecting revenue leverage and digital marketing efficiencies.
  • Healthcare Industry Backdrop Remains FavorableManagement cited the replenishment-driven and essential nature of healthcare apparel and stated that the Bureau of Labor Statistics projects healthcare to add about 37% of all new jobs over the next decade. The company also said healthcare jobs created over the past year exceeded job creation in the overall economy.
  • Impact and Community Initiatives ExpandedFIGS partnered with Operation Walk Los Angeles and St. Elizabeth Hospital to provide more than 40 free joint replacements in the Philippines. Its Kenya operating theater has supported more than 2,500 surgeries for a community of 500,000 Kenyans, and FIGS launched a dedicated initiative with OOG Health while entering a collaboration agreement covering marketing, data, and AI benefits.
  • Positive Customer and Demand IndicatorsManagement reported site traffic up mid-30s, social following up nearly 40% year-over-year, and email and SMS subscriber growth of more than 30%. New customer cohorts had higher average order values, while returning customer cohorts showed improving order frequency and spend.
  • Net Income and EPS ImprovedQ3 net income increased to $19.3 million, or diluted EPS of $0.10, from net income of $8.7 million and diluted EPS of $0.05 in the prior-year period.

FIGS Earnings History

FIGS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.14-0.1――
Nov 05, 20262026 (Q3)0.070.100.05100.00% (+0.05)
Aug 06, 20262026 (Q2)0.070.150.04275.00% (+0.11)
May 07, 20262026 (Q1)0.010.030―
Feb 26, 20262025 (Q4)0.020.100.01900.00% (+0.09)
Nov 06, 20252025 (Q3)0.020.05-0.01600.00% (+0.06)
Aug 07, 20252025 (Q2)0.020.040.01300.00% (+0.03)
May 08, 20252025 (Q1)0.000.000.01-100.00% (-0.01)
Feb 27, 20252024 (Q4)0.010.010.05-80.00% (-0.04)
Nov 07, 20242024 (Q3)-0.01-0.010.03-133.33% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed